Sameh Eldaly | Rehabilitation | Young Scientist Award

Dr. Sameh Eldaly | Rehabilitation | Young Scientist Award 

Student at  Cairo University, Egypt

Sameh Tamer Moustafa Eldaly is a passionate and skilled physiotherapist with a B.Sc. in Physiotherapy from Cairo University, Egypt.  With certifications in sports medicine, nutrition, and spinal injury management, he specializes in innovative rehabilitation approaches like dry needling, cupping therapy, and the McKenzie Method.  A member of esteemed global associations like the Australian Physiotherapy Association and the Swedish Research Council for Sport Science, he combines hands-on clinical expertise with a strong academic and research background.  Sameh has contributed to physiotherapy advancements through international conference presentations, publications, and practical innovations such as mobile rehabilitation applications.  Committed to excellence, he has volunteered in medical convoys and served on advisory committees for injury treatment plans.  He also authored the book Clinical Guidelines in Orthopaedic Rehabilitation, demonstrating his dedication to enhancing patient outcomes and advancing the physiotherapy field.

Profile

Scholar

Orcid

Education 🎓

B.Sc. in Physiotherapy – Cairo University, Egypt FIFA Diploma in Football Medicine.  Diploma in Nutrition from Oxford Center. Stanford’s Introduction to Food and Health 🍴“21 Nutrition & Diet Planning Myths & Mistakes”. Physiotherapy Management of Spinal Cord Injuries 🦴Certified Peer Reviewer .  He blends advanced knowledge in physiotherapy with interdisciplinary expertise in nutrition, rehabilitation, and research methodology, reflecting a robust academic foundation for holistic patient care.

Experience 💼

Head of Physiotherapy Department at Dr. Mohammed Algindi’s Clinic   Worked with Dr. Hisham El-Waseef at Al-Borg Center for Physiotherapy and Nutrition . Advisory team member for injury monitoring and treatment planning in Palestine and Gaza. Internships Egyptian Society for Physiotherapy and Prosthetics in Port Said  Kasr Al-Ainy French and Old Hospitals  Children’s Egypt Center in Maadi  Actively involved in medical convoys with Resala Charity Organization

Awards and Honors 🏅

FIFA Diploma in Football Medicine Diploma in Nutrition from Oxford Center  Recognition for research presented at the 22nd International Physical Therapy Conference (IPTCCU) Speaker at the International Rehabilitation and Wellbeing Congress. His accolades highlight his commitment to blending clinical skills with academic contributions, promoting rehabilitation excellence globally.

Research Focus 🔬

Extracorporeal shock wave therapy and neuromuscular junctions. Low-level LASER therapy for Achilles tendinopathy. Electrical muscle stimulation (EMS) for occupational activities . EMS benefits for shoulder instability rehabilitation

📚Publications 

“Electrical muscular stimulation on shoulder instability: is it beneficial?” (DOI: 10.21203/rs.3.rs-4126463/v1, 2024).

“Clinical Guidelines in Orthopedic Rehabilitation” (ISBN: 978-977-86894-2-6, 2023).

“Effect of extracorporeal shock waves on neuromuscular junctions vs. carpal tunnel syndrome” (DOI: 10.53730/ijhs.v7nS1.14521, 2023).

“Effect of Electrical Muscular Stimulation on Occupational Activities” (DOI: 10.21203/rs.3.rs-3140703/v1, 2023)

Conclusion

Sameh Tamer Moustafa Eldaly is an outstanding candidate for the Young Scientist Award, with a remarkable blend of clinical expertise, research innovation, and technological contributions to physiotherapy. His commitment to evidence-based practice and community service aligns well with the spirit of the award. By diversifying his research focus and pursuing advanced academic qualifications, Sameh can further enhance his impact and leadership in the field. His achievements make him highly deserving of recognition as a rising star in physiotherapy and rehabilitation sciences.

Ourania Kotsiou | Airways Disease |Best Researcher Award

Dr. Ourania Kotsiou | Airways Disease | Best Researcher Award

Dr. Ourania S. Kotsiou is an Assistant Professor of Human Pathophysiology at the University of Thessaly, specializing in respiratory diseases. She earned her PhD from the University of Thessaly, focusing on biomarkers in pleural diseases. Her expertise includes research in asthma, COPD, and the role of exosomes in airway inflammation. Dr. Kotsiou combines clinical practice with research and has been honored with numerous awards for her contributions to pulmonary medicine.

Publication profile

Orcid

Scholar

 

Evaluation of Dr. Ourania S. Kotsiou for the Best Researcher Award

🏆 Strengths for the Award:

Expertise in Respiratory Diseases: Dr. Kotsiou’s extensive research in asthma, COPD, and pleural effusion showcases her deep expertise in respiratory medicine, particularly in understanding molecular mechanisms and developing innovative therapies such as anti-IL-5 biologics. High Research Output: With 90 publications in reputable journals (PubMed-indexed) and a substantial total impact factor of 549.663, her contributions have significantly advanced pulmonary research. Her h-index of 16 and i10-index of 29 underscore the quality and influence of her research. Leadership in Research Projects: Dr. Kotsiou has led multiple high-impact research projects, including a GlaxoSmithKline-funded study on severe asthma, which highlights her ability to manage and contribute to cutting-edge research in the field. Strong Academic Presence: As an Assistant Professor at the University of Thessaly, she has an established academic profile, contributing to both teaching and research, while also collaborating with prestigious organizations such as the European Respiratory Society (ERS). Editorial Contributions: Her involvement as an editorial board member and guest editor for international journals, such as Scientific Reports (Nature), demonstrates her leadership and recognition in the academic community.

🔧 Areas for Improvements:

Patent Applications: Dr. Kotsiou does not currently hold any patents, which could enhance her profile by highlighting her contributions to innovative treatment methods or diagnostic tools in pulmonary medicine. Public and Community Outreach: Increased involvement in community outreach programs or extension activities related to public health awareness and respiratory disease prevention could strengthen her candidacy for awards related to societal impact.

📖 Books Published (ISBN)

Contributor to 16 book sections or chapters.

🏆 Contributions 

Dr. Kotsiou has made significant strides in understanding asthma and COPD, focusing on molecular mechanisms and innovative therapies like anti-IL-5 biologics. Her research has influenced better treatment approaches, enhancing patient outcomes.

💡 Research and Innovations:

Completed/Ongoing Research Projects: Chief Investigator: GlaxoSmithKline-funded study on severe asthma and anti-IL-5 treatment (2020-2024). Sub-Investigator: PRINCIPLE, PRECURSOR, PHOLLOW, ISABELA1 studies (2019-2024). Research Fellow in HTS-funded projects on COPD and asthma. Citation Index: 1136 (Google Scholar), h-index: 16, i10-index: 29. Consultancy/Industry Projects: Collaborations with Pfizer, AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline.

Publication top notes

  • Title: IL-33/ST2 axis in organ fibrosis
    Authors: OS Kotsiou, KI Gourgoulianis, SG Zarogiannis
    Journal: Frontiers in Immunology
    Year: 2018
    Volume/Issue: 9, 2432

 

  • Title: Acceptability of COVID-19 vaccination among Greek health professionals
    Authors: D Papagiannis, G Rachiotis, F Malli, IV Papathanasiou, O Kotsiou, et al.
    Journal: Vaccines
    Year: 2021
    Volume/Issue: 9(3), 200

 

  • Title: Impact of the refugee crisis on the Greek healthcare system: a long road to Ithaca
    Authors: OS Kotsiou, P Kotsios, DS Srivastava, V Kotsios, KI Gourgoulianis, et al.
    Journal: International Journal of Environmental Research and Public Health
    Year: 2018
    Volume/Issue: 15(8), 1790

 

  • Title: Pulmonary function testing in COPD: looking beyond the curtain of FEV1
    Authors: S Kakavas, OS Kotsiou, F Perlikos, M Mermiri, G Mavrovounis, et al.
    Journal: NPJ Primary Care Respiratory Medicine
    Year: 2021
    Volume/Issue: 31(1), 23

 

  • Title: Calprotectin in lung diseases
    Authors: OS Kotsiou, D Papagiannis, R Papadopoulou, KI Gourgoulianis
    Journal: International Journal of Molecular Sciences
    Year: 2021
    Volume/Issue: 22(4), 1706

 

  • Title: The emergency medical system in Greece: Opening Aeolus’ bag of winds
    Authors: OS Kotsiou, DS Srivastava, P Kotsios, AK Exadaktylos, KI Gourgoulianis
    Journal: International Journal of Environmental Research and Public Health
    Year: 2018
    Volume/Issue: 15(4), 745

 

  • Title: Prehospital NSAIDs use prolong hospitalization in patients with pleuro-pulmonary infection
    Authors: OS Kotsiou, SG Zarogiannis, KI Gourgoulianis
    Journal: Respiratory Medicine
    Year: 2017
    Volume/Issue: 123, 28-33

 

  • Title: Estimates of COVID-19 risk factors among social strata and predictors for vulnerability to infection
    Authors: DS Mouliou, OS Kotsiou, KI Gourgoulianis
    Journal: International Journal of Environmental Research and Public Health
    Year: 2021
    Volume/Issue: 18(16), 8701

 

  • Title: Impact of the financial crisis on COPD burden: Greece as a case study
    Authors: OS Kotsiou, S Zouridis, M Kosmopoulos, KI Gourgoulianis
    Journal: European Respiratory Review
    Year: 2018
    Volume/Issue: 27(147)

 

  • Title: Action and reaction of pre-primary and primary school-age children to restrictions during the COVID-19 pandemic in Greece
    Authors: DI Siachpazidou, OS Kotsiou, G Chatziparasidis, D Papagiannis, et al.
    Journal: Journal of Personalized Medicine
    Year: 2021
    Volume/Issue: 11(6), 451

 

📋 Conclusion:

Dr. Ourania S. Kotsiou is a highly qualified candidate for the Best Researcher Award due to her impactful research in respiratory diseases, leadership in significant clinical projects, and strong academic contributions. With a focus on further extending her innovations into patents or public health initiatives, her influence in both the academic and medical community will continue to grow. She exemplifies the qualities of a leading researcher dedicated to advancing pulmonary health.